359 related articles for article (PubMed ID: 29455662)
1. The role of RICTOR downstream of receptor tyrosine kinase in cancers.
Jebali A; Dumaz N
Mol Cancer; 2018 Feb; 17(1):39. PubMed ID: 29455662
[TBL] [Abstract][Full Text] [Related]
2. Unmasking the impact of Rictor in cancer: novel insights of mTORC2 complex.
Gkountakos A; Pilotto S; Mafficini A; Vicentini C; Simbolo M; Milella M; Tortora G; Scarpa A; Bria E; Corbo V
Carcinogenesis; 2018 Jul; 39(8):971-980. PubMed ID: 29955840
[TBL] [Abstract][Full Text] [Related]
3. mTOR-Rictor-EGFR axis in oncogenesis and diagnosis of glioblastoma multiforme.
Ramaiah MJ; Kumar KR
Mol Biol Rep; 2021 May; 48(5):4813-4835. PubMed ID: 34132942
[TBL] [Abstract][Full Text] [Related]
4. A Comprehensive Pan-Cancer Analysis of the Potential Biological Functions and Prognosis Values of RICTOR.
Sun Y; Li R; Nong B; Songyang Z; Wang X; Ma W; Zhou Q
Genes (Basel); 2023 Jun; 14(6):. PubMed ID: 37372460
[TBL] [Abstract][Full Text] [Related]
5. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt/PRAS40 in esophageal squamous cell carcinoma.
Hou G; Zhao Q; Zhang M; Fan T; Liu M; Shi X; Ren Y; Wang Y; Zhou J; Lu Z
Biomed Pharmacother; 2018 Oct; 106():1348-1356. PubMed ID: 30119206
[TBL] [Abstract][Full Text] [Related]
7. Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition.
Ruicci KM; Plantinga P; Pinto N; Khan MI; Stecho W; Dhaliwal SS; Yoo J; Fung K; MacNeil D; Mymryk JS; Barrett JW; Howlett CJ; Nichols AC
Mol Oncol; 2019 Oct; 13(10):2160-2177. PubMed ID: 31393061
[TBL] [Abstract][Full Text] [Related]
8. Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical implications.
Fourneaux B; Chaire V; Lucchesi C; Karanian M; Pineau R; Laroche-Clary A; Italiano A
Oncotarget; 2017 Jan; 8(5):7878-7890. PubMed ID: 28002802
[TBL] [Abstract][Full Text] [Related]
9. The role of RICTOR amplification in targeted therapy and drug resistance.
Zhao D; Jiang M; Zhang X; Hou H
Mol Med; 2020 Feb; 26(1):20. PubMed ID: 32041519
[TBL] [Abstract][Full Text] [Related]
10. Rictor phosphorylation on the Thr-1135 site does not require mammalian target of rapamycin complex 2.
Boulbes D; Chen CH; Shaikenov T; Agarwal NK; Peterson TR; Addona TA; Keshishian H; Carr SA; Magnuson MA; Sabatini DM; Sarbassov dos D
Mol Cancer Res; 2010 Jun; 8(6):896-906. PubMed ID: 20501647
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin-insensitive companion of mTOR (RICTOR) amplification defines a subset of advanced gastric cancer and is sensitive to AZD2014-mediated mTORC1/2 inhibition.
Kim ST; Kim SY; Klempner SJ; Yoon J; Kim N; Ahn S; Bang H; Kim KM; Park W; Park SH; Park JO; Park YS; Lim HY; Lee SH; Park K; Kang WK; Lee J
Ann Oncol; 2017 Mar; 28(3):547-554. PubMed ID: 28028034
[TBL] [Abstract][Full Text] [Related]
12. Rictor/mTORC2 Drives Progression and Therapeutic Resistance of HER2-Amplified Breast Cancers.
Morrison Joly M; Hicks DJ; Jones B; Sanchez V; Estrada MV; Young C; Williams M; Rexer BN; Sarbassov dos D; Muller WJ; Brantley-Sieders D; Cook RS
Cancer Res; 2016 Aug; 76(16):4752-64. PubMed ID: 27197158
[TBL] [Abstract][Full Text] [Related]
13. Rictor promotes tumor progression of rapamycin-insensitive triple-negative breast cancer cells.
Watanabe R; Miyata M; Oneyama C
Biochem Biophys Res Commun; 2020 Oct; 531(4):636-642. PubMed ID: 32819718
[TBL] [Abstract][Full Text] [Related]
14. The Role of Mammalian Target of Rapamycin (mTOR) in Insulin Signaling.
Yoon MS
Nutrients; 2017 Oct; 9(11):. PubMed ID: 29077002
[TBL] [Abstract][Full Text] [Related]
15. PCB153 suppressed autophagy via PI3K/Akt/mTOR and RICTOR/Akt/mTOR signaling by the upregulation of microRNA-155 in rat primary chondrocytes.
Liu Z; Huang Y; Jin X; Liu L; Gu H
Toxicol Appl Pharmacol; 2022 Aug; 449():116135. PubMed ID: 35732230
[TBL] [Abstract][Full Text] [Related]
16. Rictor/mTORC2 pathway in oocytes regulates folliculogenesis, and its inactivation causes premature ovarian failure.
Chen Z; Kang X; Wang L; Dong H; Wang C; Xiong Z; Zhao W; Jia C; Lin J; Zhang W; Yuan W; Zhong M; Du H; Bai X
J Biol Chem; 2015 Mar; 290(10):6387-96. PubMed ID: 25564616
[TBL] [Abstract][Full Text] [Related]
17. mTORC1 and mTORC2 regulate insulin secretion through Akt in INS-1 cells.
Le Bacquer O; Queniat G; Gmyr V; Kerr-Conte J; Lefebvre B; Pattou F
J Endocrinol; 2013 Jan; 216(1):21-9. PubMed ID: 23092880
[TBL] [Abstract][Full Text] [Related]
18. Increased Levels of Rictor Prevent Mutant Huntingtin-Induced Neuronal Degeneration.
Creus-Muncunill J; Rué L; Alcalá-Vida R; Badillos-Rodríguez R; Romaní-Aumedes J; Marco S; Alberch J; Perez-Otaño I; Malagelada C; Pérez-Navarro E
Mol Neurobiol; 2018 Oct; 55(10):7728-7742. PubMed ID: 29460266
[TBL] [Abstract][Full Text] [Related]
19. ETV7 is an essential component of a rapamycin-insensitive mTOR complex in cancer.
Harwood FC; Klein Geltink RI; O'Hara BP; Cardone M; Janke L; Finkelstein D; Entin I; Paul L; Houghton PJ; Grosveld GC
Sci Adv; 2018 Sep; 4(9):eaar3938. PubMed ID: 30258985
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneous nuclear ribonucleoprotein M associates with mTORC2 and regulates muscle differentiation.
Chen WY; Lin CL; Chuang JH; Chiu FY; Sun YY; Liang MC; Lin Y
Sci Rep; 2017 Jan; 7():41159. PubMed ID: 28106162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
